OpenVSafe by OpenVAERS
Search V-safe

N9X-19784-50738

2 vaccinations 2 coded responses 22 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
971 / OR
Registered
2021-12-04
Relationship
Child or adolescent in my care
Guardian
ZBJ-33811-81473
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-12-04
    Registered in v-safe
  2. 2021-12-04
    Dose 1 — Pfizer-BioNTech
  3. 2021-12-04
    Health check-in — day 0, dose 1, dependent
    Feeling: Fair · Site: Pain · None
    Adult check-in
  4. 2021-12-05
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-12-06
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-12-07
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-12-09
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-12-11
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  9. 2021-12-21
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  10. 2022-01-03
    Survey response — day 28, dose 1, dependent
    MedDRA: Norovirus infection — Feeling: Good · Be unable to do your normal daily activities
    Free text: She had norovirus
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-01-08
    Dose 2 — Pfizer-BioNTech
  12. 2022-01-08
    Health check-in — day 0, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2022-01-09
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2022-01-10
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None · Be unable to do your normal daily activities
    Adult check-in
  15. 2022-01-12
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  16. 2022-01-13
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  17. 2022-01-14
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  18. 2022-01-17
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  19. 2022-01-24
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  20. 2022-01-29
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  21. 2022-02-05
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  22. 2022-02-12
    Survey response — day 35, dose 2, dependent
    MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school
    Free text: Runny nose and nasal congestion
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-02-19
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  24. 2022-04-10
  25. 2022-07-12

Vaccinations

DoseDateManufacturerCo-administered
12021-12-04Pfizer-BioNTech No
22022-01-08Pfizer-BioNTech No

Free text

Release 10 — day 28, dose 1, dependent

2022-01-03

Symptoms: She had norovirus

Release 11 — day 35, dose 2, dependent

2022-02-12

Symptoms: Runny nose and nasal congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasal congestion · · ✓
SDNorovirus infection · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…